\-\ Texto\\:\\ \ \(0\)\
\-\ elevated\\ serum\\ calcium\\ and\\ parathyroid\\ hormone\\ levels\ \(2\)\
\-\ persistent\\ focal\\ increased\\ activity\\ in\\ the\\ inferior\\ region\\ adjacent\\ to\\ the\\ left\\ lower\\ pole\\ of\\ thyroid\ \(0\)\
\-\ hyperparathyroidism\\ \\-\\ parathyroid\\ adenoma\ \(0\)\
\-\ parathyroid\\ adenoma\ \(27\)\
\-\ thyroid\\ adenoma\ \(56\)\
\-\ 46\\ y\\/o\\ female\\ with\\ hypercalcemia\\ and\\ elevated\\ parathormone\\ level\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ parathyroid\\:\\ 0\\.40607407817282565\ \(0\)\
\-\ adenoma\\:\\ 0\\.2676370763854509\ \(0\)\
\-\ parathormone\\:\\ 0\\.20305928108516383\ \(0\)\
\-\ thyroid\\:\\ 0\\.17511562224623556\ \(0\)\
\-\ elevated\\:\\ 0\\.14496581806795314\ \(0\)\
\-\ hypercalcemia\\:\\ 0\\.14311189926520457\ \(0\)\
\-\ hormone\\:\\ 0\\.12113066276035943\ \(0\)\
\-\ 46\\:\\ 0\\.11312647457045269\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.11211962709200418\ \(0\)\
\-\ calcium\\:\\ 0\\.10451973589342156\ \(0\)\
\-\ serum\\:\\ 0\\.10310426354343388\ \(0\)\
\-\ pole\\:\\ 0\\.09948091292537552\ \(0\)\
\-\ levels\\:\\ 0\\.08818128483179909\ \(0\)\
\-\ persistent\\:\\ 0\\.0852086663126595\ \(0\)\
\-\ activity\\:\\ 0\\.08015116571953847\ \(0\)\
\-\ inferior\\:\\ 0\\.07248290903397657\ \(0\)\
\-\ adjacent\\:\\ 0\\.06754590610335669\ \(0\)\
\-\ level\\:\\ 0\\.0615722256911733\ \(0\)\
\-\ focal\\:\\ 0\\.06101234010346005\ \(0\)\
\-\ region\\:\\ 0\\.060340030680982815\ \(0\)\
\-\ y\\/o\\:\\ 0\\.05916572574549102\ \(0\)\
\-\ increased\\:\\ 0\\.052262119544991395\ \(0\)\
\-\ lower\\:\\ 0\\.04804655173409657\ \(0\)\
\-\ \\-\\:\\ 0\\.045793211467709094\ \(0\)\
\-\ female\\:\\ 0\\.04391900678619584\ \(0\)\
\-\ left\\:\\ 0\\.02390263173182287\ \(0\)\
\-\ to\\:\\ 0\\.010676702711074657\ \(0\)\
\-\ in\\:\\ 0\\.010534930753506373\ \(0\)\
\-\ and\\:\\ 0\\.009000450286610923\ \(0\)\
\-\ the\\:\\ 0\\.00691246423518129\ \(0\)\
\-\ with\\:\\ 0\\.0029251044022472437\ \(0\)\
\-\ of\\:\\ 0\\.0029125950199497107\ \(0\)\
